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Incoming adenovirus type 2 (Ad2) and Ad5 shuttle bidirectionally along microtubules, biased to the microtubule-
organizing center by the dynein/dynactin motor complex. It is unknown how the particles reach the nuclear pore complex,
where capsids disassemble and viral DNA enters the nucleus. Here, we identified a novel link between nuclear export and
microtubule-mediated transport. Two distinct inhibitors of the nuclear export factor CRM1, leptomycin B (LMB) and
ratjadone A (RJA) or CRM1-siRNAs blocked adenovirus infection, arrested cytoplasmic transport of viral particles at the
microtubule-organizing center or in the cytoplasm and prevented capsid disassembly and nuclear import of the viral
genome. In mitotic cells where CRM1 is in the cytoplasm, adenovirus particles were not associated with microtubules but
upon LMB treatment, they enriched at the spindle poles implying that CRM1 inhibited microtubule association of
adenovirus. We propose that CRM1, a nuclear factor exported by CRM1 or a protein complex containing CRM1 is part of
a sensor mechanism triggering the unloading of the incoming adenovirus particles from microtubules proximal to the
nucleus of interphase cells.
INTRODUCTION
Molecular crowding restricts the diffusion of macromole-
cules in the cytoplasm. Many cargo complexes use motors
for effective cytoplasmic trafficking (reviewed in Luby-
Phelps, 2000; Ploubidou and Way, 2001; Smith and Enquist,
2002). Long-range cargo transport is typically mediated by
microtubules (MTs) and MT-associated motors of the kine-
sin and dynein families. These motors transport mRNAs for
cell fate and polarity determinations (reviewed in Saxton,
2001), transcriptional regulators, such as the NF kappa B
inhibitor IB (Crepieux et al., 1997), the tumor suppressor
protein p53 (Giannakakou et al., 2000; Giannakakou et al.,
2002), the developmental factors -catenin or adenomatous
poliposis coli protein (APC, reviewed in Bienz, 2002), the
apoptosis effector bim (Puthalakath et al., 1999), and stress-
related signaling kinases of the ERK and JNK families (re-
viewed in Verhey and Rapoport, 2001). Many of these fac-
tors act in the nucleus but it is not known how they are
released from the MTs to gain access to the nucleoplasm.
Microorganisms and many viruses prominently abuse the
MT shuttling system (Sodeik, 2000; Ploubidou and Way,
2001; Smith and Enquist, 2002; Grieshaber et al., 2003). Dur-
ing entry, viruses take advantage of the dynein/dynactin
motor complex for directional transport to the MT minus
ends organized at the centrosome, the MT-organizing center
(Bornens, 2002). This has been demonstrated for adenovi-
ruses (Suomalainen et al., 1999; Leopold et al., 2000; Suoma-
lainen et al., 2001; Mabit et al., 2002; Kelkar et al., 2004),
herpes viruses (Dohner et al., 2002; Douglas et al., 2004), the
lentivirus human immunodeficiency virus 1 (McDonald et
al., 2002), the retroviruses human foamy virus 13 and Ma-
son-Pfizer monkey virus (Petit et al., 2003; Sfakianos et al.,
2003), canine parvovirus (Suikkanen et al., 2003), endosomal
influenza virus (Lakadamyali et al., 2003), African swine
fever virus (Alonso et al., 2001; Jouvenet et al., 2004), and the
P-protein polymerase complex of rabies virus (Jacob et al.,
2000; Raux et al., 2000; Finke et al., 2004). Like for cellular
cargoes, it is unknown how the motor interactions with MTs
are regulated and how the cargo is released from the motors
at the final destination.
Adenovirus enters the nucleus by binding to the cytoplas-
mic fibril protein CAN/Nup214 of the nuclear pore com-
plex, dismantles the capsid and releases the DNA into the
nucleoplasm (Greber et al., 1996; Trotman et al., 2001; Martin-
Fernandez et al., 2004). In this study, we asked if nuclear
protein export provides a link between the nucleus and the
perinuclear cytoplasm to inform the virus about the nuclear
position in the cytoplasm. The nuclear export factor CRM1
(chromosome region maintenance 1) predominantly local-
izes to the nucleus and exports leucine-rich nuclear export
sequence (NES) containing proteins (Fornerod et al., 1997a).
The loading of CRM1 to proteins containing physiological
NESs in the nucleus is assisted by Ran:GTP, whereas cargo
discharge occurs in the cytoplasm or the cytoplasmic face of
the NPC upon stimulation of Ran:GTP hydrolysis by Ran-
GAP (Mahajan et al., 1997; Gorlich and Kutay, 1999). Our
results indicate that the targeting of incoming adenovirus
from MTs to the NPC requires CRM1 activity. Treating a
variety of different cells with CRM1-specific siRNAs or in-
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hibitors of CRM1, such as leptomycin B (LMB) or ratjadone
A (RJA) strongly reduced adenovirus infection and blocked
the nuclear targeting of viral particles, the disassembly of
capsids and the import of viral DNA. In most cell types
tested, LMB or RJA blocked the cytoplasmic transport of
adenovirus at the MTOC and in one cell line the block
occurred in the cytoplasm, precluding viral attachment to
the NPC. We suggest that in normal cells CRM1 or a nuclear
factor exported by CRM1 dissociates adenovirus particles
from MTs in the perinuclear region and thus enables viral
binding to NPCs and infection.
MATERIALS AND METHODS
Cells, Transfection, and Viruses
TC7 (African green monkey kidney) cells were obtained from J. Bulinski
(Columbia University, New York) and used as described (Suomalainen et al.,
1999). HeLa cells (obtained from American Type Culture Collection, Rock-
ville, MD), human lung carcinoma A549 cells, Ad5-E1 transfected human
embryonic retinoblast 911 cells (Fallaux et al., 1998), human epithelial KB cells
(obtained from American Type Culture Collection), human epithelial carci-
noma cells A431 (obtained from J. Pavlovic, Institute of Medical Virology,
University of Zu¨rich, Switzerland), African green monkey kidney cells CV1
(American Type Culture Collection) and COSN cells, a subline of COS7 cells
containing origin-defective SV40 DNA (Gluzman, 1981) obtained from S.
Hemmi (Institute of Molecular Biology, University of Zu¨rich, Switzerland;
Hemmi et al., 1994) were grown in 10% fetal bovine serum or 7% clone III
serum (Hyclone, PerBio Science, Lausanne, Switzerland) on alcian blue-
coated glass coverslips (Suomalainen et al., 1999). Freshly isolated, primary
human umbilical vein endothelial cells (HUVEC) were a gift of L. Jornot
(Respiratory Division, University Hospital Geneva, Switzerland) and were
grown in RPMI 1640 plus 15% fetal calf serum and 15 g/ml endothelial
growth factor and 90 g/ml heparin (Invitrogen, Basel, Switzerland). Primary
human fibroblasts isolated from human foreskin were provided by S. Hemmi
(Institute of Molecular Biology, University of Zu¨rich, Switzerland). Plasmid
DNAs were transfected into 50% confluent HeLa or TC7 cells grown on
12-mm coverslips using FuGENE 6 (Roche, Indianapolis, IN) according to the
manufacture’s protocol. Wild-type Ad2 and the mutant temperature sensitive
(ts) Ad2 ts1 were grown, isolated, and labeled with TR as published (Greber
et al., 1998; Nakano and Greber, 2000). Ad5-luc was used as described (Mabit
et al., 2002).
Antibodies and Chemicals
Rabbit anti-hexon R70 antibodies were provided by M. Horwitz (Albert
Einstein College of Medicine, New York), and rabbit anti-protein VII antibod-
ies were from U. Pettersson (Uppsala University, Sweden) and used as
described (Greber et al., 1993, 1997; Trotman et al., 2001). -tubulin was
visualized using the mouse monoclonal antibody TU-30 from P. Draber
(Institute of Molecular Genetics, Prague, Czech Republic) used as described
Figure 1. LMB and RJA inhibit adenovi-
rus-mediated gene expression. TC7 (A and
C) or HeLa (B and D) cells were treated with
LMB (A and B) or RJA (C and D), incubated
with Ad5-luc in the cold for 60 min (2.9 
104 particles per cell), washed, and analyzed
for luciferase activity 4 h postinfection. The
mean values of triplicate samples from one
typical experiment are shown as relative
light units (rlu), normalized to the number
of cells, including the SEs of the mean from
triplicate samples. (E) The average fold in-
hibition of normalized luciferase activity in
TC7, HeLa, A549, 911, KB, COSN, CV1,
A431, normal human foreskin fibroblasts
(2N), and HUVEC cells treated with 20 nM
LMB, compared with non–drug-treated
cells. The mean values of triplicate samples
are shown. Independently, the subcellular
localization of Ad2-TR in the 20 nM LMB-
treated cells was scored: () indicating
MTOC-arrest, () random cytoplasmic dis-
tribution and not determined phenotypes
(n.d.). The viability of the cells treated with
20 nM LMB and infected with Ad5-luc was
measured by metabolic labeling with
[35S]methionine (F).
S. Strunze et al.
Molecular Biology of the Cell3000
(Suomalainen et al., 1999). Cells were fixed in 3% pFA for 10 min and extracted
with methanol at 20°C for 5 min or were directly fixed and extracted in
chilled methanol at 20°C for 4 min (Suomalainen et al., 1999). The anti-
tyrosinated -tubulin antibody 1A2 (Kreis, 1987) was used on PHEMO fixed
cells as described (Mabit et al., 2002). Rabbit anti-CRM1 was obtained from M.
Fornerod (Fornerod et al., 1997b) and rabbit antinuclear lamins A, B, and C
peptide antibody 8188 was supplied by L. Gerace (Scripps Research Institute,
La Jolla, CA; Greber et al., 1997). Rabbit anti-calnexin antibody was provided
by A. Helenius (ETH Zu¨rich, Switzerland). Goat IgG against mouse IgG
coupled to Alexa 350, 488, or 594 were from Molecular Probes (Leiden, The
Netherlands) and goat anti-mouse coupled to Cy5 from Jackson ImmunoRe-
search (West Grove, PA). DAPI (Molecular Probes) was used as indicated by
the manufacturer. HRP conjugated-goat anti-rabbit antibody was from Sigma
(Sigma, Fluka, Buchs, Switzerland). LMB, a generous gift of B. Wolff (Novartis
Forschungsinstitut, Vienna, Austria), was dissolved in dimethyl sulfoxide
(DMSO) and kept at 20°C until use. Nocodazole, thymidine and RJA were
purchased from Sigma. Control treatments included DMSO alone at the
carrier concentration of 0.1% (vol/vol).
siRNA Experiments
CRM1 targeting siRNA (sense UGUGGUGAAUUGCUUAUACd(TT); anti-
sense GUAUAAGCAAUUCACCACAd(TT); Lund et al., 2004) and nonsilenc-
ing control siRNA were obtained from Qiagen (Hilden, Germany). HeLa cells
were transfected with 16.6 or 80 pmol of siRNA at a confluency of 40–50% in
24-well dishes on 12-mm coverslips or six-well dishes, respectively, using
Oligofectamine and Opti-MEM reduced serum medium (Invitrogen), and
infected with Ad5-eGFP 46 h posttransfection.
Western Blot Analysis
HeLa cells grown in 35-mm dishes were washed with phosphate-buffered
saline (PBS) and lysed in 300 l of 2% hot SDS. The lysate was passed through
a 20-gauge needle several times and heated to 95°C for 30 s. After centrifu-
gation at 16,000  g for 10 min, 150 l of the supernatant was mixed with 50
l of sample buffer (200 mM Tris/HCl, pH 6.8, 8% SDS, 0.4% bromphenol
blue, 40% glycerol, 167 mM dithiothreitol) and heated to 95°C for 10 min.
Extracts were separated on 10% SDS-PAGE, transferred to Hybond-ECL
nitrocellulose membrane (Amersham Biosciences, Zurich, Switzerland), and
blocked with 5% (wt/vol) dried milk in 50 mM Tris/100 mM sodium chlo-
ride/0.1% Tween, pH 7.4 (TNT). After immunological probing HRP-conju-
gated antibodies were detected with ECL Plus reagents (Amersham Bio-
sciences). Filters were stripped with 100 mM -mercaptoethanol, 2% SDS, 62.5
mM Tris/HCl, pH 6.7, at 50°C for 30 min, washed extensively with TNT,
blocked with 5% dried milk, and reprobed with an anti-calnexin antibody.
Transferrin Uptake
HeLa cells were serum starved for 4 h in DMEM-bovine serum albumin
medium and incubated with 20 g/ml human transferrin–labeled with Al-
exa647 (Molecular Probes) for 30 min, washed briefly and chased in trans-
ferrin-free medium for 10 min, fixed in 3% paraformaldehyde, and processed
for immunofluorescence using CRM1-specific antibodies.
Metabolic Labeling
TC7 cells grown in 35-mm-diameter dishes were treated with or without 20
nM LMB and infected with Ad5-luc. One hour before lysis cells were starved
in methionine-free, serum-free medium (Life Technologies, Invitrogen) at
37°C for 20 min and pulse-labeled with 5 Ci [35S]methionine for 40 min as
described (Imelli et al., 2004). Cells were washed with PBS, lysed in Ripa
buffer (20 mM Tris/HCl, pH 7.4, 130 mM NaCl, 2 mM EDTA, 0.1% SDS, 0.5%
deoxycholate, 1% Triton X-100) and protease inhibitors (1 mM phenylmeth-
ylsulfonyl fluoride and 1 g each of chymostatin, leupeptin, aprotinin, and
pepstatin/ml), precipitated with trichloroacetic acid, and incorporated radio-
activity was analyzed in a liquid scintillation counter (Beckman Coulter,
Krefeld, Germany) as described (Greber et al., 1993).
Cell Cycle Synchronization
Exponentially growing cells were treated with 2 mM thymidine (Sigma) for
16 h, washed twice with serum-free medium, and released in normal medium
Figure 2. Knockdown of cellular CRM1
by siRNA reduces nuclear targeting of
Ad2. (A) HeLa cells were transfected
with siRNA specific for CRM1 or nonsi-
lencing siRNA. Cell lysates were ana-
lyzed by Western blotting using anti-
CRM1 (a) and anti-calnexin antibodies
(b), respectively. (B) CRM1 specific
siRNA (red) or nonsilencing siRNA
(black) transfected HeLa cells were in-
fected with eGFP-expressing Ad at 46 h
posttransfection, immunolabeled for
CRM1 detection, and analyzed by flow
cytometry of eGFP fluorescence (a) and
CRM1 (b). (C) CRM1-siRNA and nonsi-
lencing siRNA-transfected cells were in-
cubated with Ad2-TR in the cold for 1 h,
warmed for 40 min, pulsed with trans-
ferrin-647, fixed 80 min postinfection,
and immunolabeled for CRM1. The nu-
clei are stained with DAPI and DIC im-
ages are included for reference. Projec-
tions of entire stack of CLSM images are
shown. Bar, 10 m.
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for 12 h 10 min (adopted from Fang et al., 1998). Cells were treated with 20 nM
LMB for 20 min and infected with Ad2-TR for 1 h, fixed in PHEMO, and
processed for immunofluorescence as described above.
Ad5-luc and Ad5-eGFP Measurements
Triplicate sets of cells were grown on 24-well dishes in DMEM in the presence
of 7% clone III, treated with drugs for 20 min, incubated with Ad5-luc on ice
for 60 min, and warmed for 4 h. Cells were washed with PBS and lysed in 400
l of lysis buffer (Luciferase Assay System, Promega, Madison, WI). Lysate, 20
l, was mixed with 50 l luciferase substrate and chemiluminescence was
measured as described (Mabit et al., 2002). In parallel dishes the cell numbers
were determined by crystal violet staining and spectrophotometry at 590 nm.
For eGFP measurements, HeLa cells grown in six-well dishes were infected
with 2 g of Ad5-eGFP 46 h posttransfection of siRNA. Cells were washed
with PBS and detached from the dish by trypsinization 5 h postinfection. Cells
were permeabilized with 0.25% Triton X-100, blocked with 10% goat serum
cells, and immunolabeled with a primary CRM1-specific antibody (Fornerod
et al., 1997b), followed by a Cy5-conjugated secondary antibody (Jackson
ImmunoResearch). Samples were analyzed by flow cytometry in a Beckman
Coulter FC500 Cytometer equipped with a 488-nm Argon laser and a 638-nm
solid state laser.
Microscopy of Infected Cells
Cells grown on 12-mm coverslips were treated with drugs for 20 min and
incubated with 0.2–0.5 g Ad2-TR or 50 g Ad2 per 0.25 ml cold RPMI-
bovine serum albumin binding medium for 45–60 min in the presence or
absence of drugs. Unbound virus was washed off and cells were incubated in
DMEM-bovine serum albumin with or without drug at 37°C for indicated
times, fixed in pFA (or as otherwise indicated), quenched with 25 mM NH4Cl
in PBS at room temperature for 5 min, and permeabilized with 0.5% Triton
X-100 in PBS for 5 min. Samples were mounted in 3 l mounting medium
(DAKO, Carpinteria, CA) and analyzed by confocal laser scanning micros-
copy on a Leica SP2 microscope (Heerbrugg, Switzerland; 63 oil-immersion
objectives) using UV excitation 351 and 364 nm, FITC 468 nm, TR 568 nm, Cy5
647 nm and long-pass emission filters in sequential recording modes at
0.5-m section thickness. Fluorescence in situ hybridizations were carried out
as described (Greber et al., 1997). Quantification of the subcellular localization
of Ad2-TR was performed as described (Nakano and Greber, 2000). Electron
microscopy and Ad2 particle quantifications were carried out as described
(Nakano et al., 2000).
RESULTS
CRM1-mediated Nuclear Export Required for Adenovirus
Transduction
Nuclear export is a key process in viral infections and cell
communication, e.g., directly involved in HIV genomic RNA
assembly in the cytoplasm (for reviews, see Komeili and
O’Shea, 2000; Cullen, 2003). We examined if nuclear export
was required for adenovirus infection of cultured epithelial
cells. HeLa or TC7 cells were treated with different concen-
trations of LMB, which covalently binds to CRM1 and sup-
presses CRM1 binding to hydrophobic NESs (Fukuda et al.,
1997; Ossareh-Nazari et al., 1997; Wolff et al., 1997; Koster et
al., 2003). We also used RJA, another specific inhibitor of
CRM1 (Koster et al., 2003). Cells were treated with inhibitors
for 30 min, inoculated with luciferase expressing transgenic
adenovirus (Ad-luc) in the presence or absence of the drugs,
and scored for luciferase activity 4 h postinfection. In both
cell types, we measured a dose-dependent inhibition of lu-
ciferase activity with maximal effects of 20–50-fold at con-
centrations larger than 7.5 nM LMB and 2 ngml1 RJA,
respectively (Figure 1, A–D). Nuclear export of the indicator
protein 2xNES-eGFP was strongly suppressed in TC7 and
HeLa cells (unpublished data) using, for example, 20 nM
LMB or 10 ngml1 RJA, indicating that the drugs were
effective as expected (see Figure 3). Interestingly, at lower
doses of LMB (1 nM) and RJA (0.1–0.3 ngml1), we ob-
served an increased Ad-luc expression in both cell types, in
the range of 0.1–2-fold compared with no-drug–treated cells
(Figure 1, A–D). LMB or RJA concentrations blocking nu-
clear export, however, inhibited Ad-luc expression (Figure 1,
A and C), ranging from 4.4- to 77-fold, depending on the
cells tested (Figure 1E). The strongest effects were obtained
in cells that expressed the highest levels of luciferase, i.e.,
human embryonic retinoblast 911 cells, followed by KB,
HeLa, A549, COSN, and TC7 cells. The weakest LMB inhi-
bitions were in the range of 4–10-fold in cells that were
poorly infected with Ad5-luc, i.e., CV1 cells, the primary
human foreskin fibroblasts (2N), and HUVECs. To control
for cell integrity, we assessed the metabolic state of the
LMB-treated cells. A dose of 20 nM LMB for 5 h did not
induce any cytopathic effects indicated by viability/cytotox-
icity live cell assays (unpublished data) and metabolic incor-
poration of [35S]methionine (Figure 1F), confirming the se-
lectivity of the drugs.
We next tested if the inhibition of adenovirus transduction
by LMB and RJA was specifically due to CRM1 inactivation.
HeLa cells were treated with CRM1 specific siRNAs for 46 h,
infected with GFP-expressing adenovirus (Ad5-eGFP) for
5 h and analyzed for eGFP and CRM1 expression by flow
cytometry (Figure 2). The CRM1 levels were reduced by
40% in the CRM1 siRNA-treated cells as indicated by
Western blotting and flow cytometry (Figure 2, A and B),
and eGFP expression was significantly lower than that in the
control siRNA-treated cells, whereas the number of nonin-
fected cells increased (Figure 2B, left peak). We observed no
signs of toxicity, and this was confirmed by immunofluores-
cence analyses of cells labeled with transferrin-Alexa647-
Figure 3. LMB and RJA inhibit the nu-
clear export of 2xNES-eGFP and nuclear
targeting of adenovirus. TC7 cells trans-
fected with plasmid DNA encoding
2xNES-eGFP for 24 h were treated or not
treated with 20 nM LMB or 10 ngml1
RJA, incubated with Ad2-TR in the cold,
and warmed for 0 or 80 min. Entire
stacks of CLSM images are shown for
2xNES-eGFP (NES-GFP, green) and
Ad2-TR (red), and sections across the
cell center for DAPI stainings of DNA.
Bar, 10 m.
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and Texas Red-labeled Ad2 (Ad2-TR, Figure 2C). The CRM1
siRNA-treated cells had significantly less CRM1 that con-
trols treated with nonsilencing siRNA. Both populations
readily internalized transferrin and Ad2-TR, as indicated by
perinuclear endosomes and cytoplasmic viral puncta. Strik-
ingly, the nuclear accumulation of adenovirus was strongly
reduced in cells treated with CRM1-specific siRNA, similar
to the LMB-treated cells (Figure 1). We also noticed that
reduced nuclear targeting of adenovirus was only observed
in cells with significant CRM1 silencing effects and that
prolonged treatments with the CRM1 siRNAs reduced cell
viability, consistent with previous observations (Lund et al.,
2004). Together, this data indicated a specific requirement of
CRM1 for nuclear targeting and infection of adenovirus.
LMB Arrests Microtubule-dependent Cytoplasmic
Transport of Adenovirus at the MTOC
Because LMB or RJA blocked CRM1 more efficiently than
the CRM1 siRNAs, we used short treatments of TC7 cells
with LMB to knock down CRM1 and investigate the nature
of the CRM1 block on adenovirus entry. In both control and
CRM1-inhibited cells, Ad2-TR was found to be evenly dis-
tributed across the cells 0 min after warming, whereas virus
was enriched only at the nucleus of the control cells 80 min
postinfection (Figure 3). The incoming Ad2-TR was clus-
tered in the LMB- or RJA-treated cells predominantly at a
single spot near the nucleus. The efficacy of LMB and RJA in
these cells was controlled by transfection of the nuclear
Figure 4. Adenovirus arrests at the
MTOC of LMB-treated TC7 cells. (A)
Cells were pretreated with or without 20
nM LMB in growth medium for 30 min,
exposed to Ad2-TR in the cold for 60
min, warmed for indicated times with or
without LMB, and fixed with pFA (at 0
min postinfection pi) or methanol (40
and 80 min postinfection). The MTOC
was immunolabeled by with an -tubu-
lin antibody. The projections of the com-
plete stacks of confocal sections are
shown. DIC images are included as a
reference. Bar, 10 m. (B) Thin-section
electron micrographs across the centro-
somes of Ad2-infected LMB-treated TC7
cells 120 min postinfection. Note the lo-
calization of viral particles (arrowheads)
in the pericentriolar matrix near the cen-
trioles (arrows).
Cytoplasmic Transport and Nuclear Export
Vol. 16, June 2005 3003
export sequence bearing GFP (2xNES-eGFP) indicator pro-
tein showing a clear reduction of NES-GFP signal in the
cytoplasm of LMB- or RJA-treated cells (Figure 3). These
reductions were not complete but were identical to a previ-
ous report reflecting the nature of the NES-eGFP construct
(Saydam et al., 2001). The enrichment of incoming adenovi-
rus at the perinuclear punctum was time-dependent, al-
ready visible at 40 min and increased at 80 min postinfection
(Figure 4). This effect was also confirmed by subcellular
quantification of Ad2-TR fluorescence (unpublished data).
Subsequent immunolabeling and EM experiments identified
the cytoplasmic puncta of the arrested viruses. An antibody
against -tubulin, an integral component of the centrosome
(Joshi et al., 1992) strongly colocalized with LMB-arrested
Ad2-TR (Figure 4A). High-resolution thin section EM of
LMB-treated cells infected with Ad2 for 120 min confirmed
that virus particles were enriched in a pericentriolar region,
near two centrioles (Figure 4B). A similar centrosomal local-
ization of incoming adenovirus was found in LMB-treated
A549, 911, COSN, CV1, normal fibroblasts, and HUVECs
(see Figure 1E) and rat kangaroo PtK2 and Vero cells using
light microscopy (unpublished data). The adenovirus en-
richment at the centrosome was completely blocked in no-
codazole-treated cells lacking MTs (Figure 5A), indicating
that LMB intercepted the incoming virus on MTs. This effect
was specific for cytosolic virus, because LMB did not affect
the formation of the MT network after cold-induced depo-
lymerization, or the trafficking of transferrin (see Figure 2) or
endosomal Ad2 mutant ts1 (unpublished data; Greber et al.,
1996). Accordingly, Ad2-TR moved bidirectionally to and
Figure 5. The MTOC arrest of adenovi-
rus in LMB-treated TC7 cells requires
MTs and also occurs in mitotic cells. (A)
TC7 cells were treated with or without
LMB (20 nM) and nocodazole (noc, 20
M), infected with Ad2-TR for 80 min,
fixed with PHEMO fix, and immuno-
stained for -tubulin (green) and DAPI
(blue). DIC images are included as a ref-
erence. Bar, 10 m. (B) Synchronized mi-
totic cells treated with or without LMB
were infected with Ad2-TR (red) for 60
min, fixed with PHEMO fix, and stained
for -tubulin (green) and DNA (DAPI,
blue). Whole-cell CLSM analyses are
shown. Note the enrichment of Ad2-TR
at spindle pole bodies of LMB-treated
mitotic cells. Bar, 10 m.
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from the MTOC in both LMB and control TC7 cells (see
Supplementary Movies S1 and S1). LMB-treated cells did,
however, not contain any viruses on their nuclei at 30 min
postinfection, unlike control cells. This effect was due to
inhibition of a cellular target rather than the virus proper,
because a centrosomal arrest of Ad2 was not observed if the
particles but not the cells were treated with LMB (unpub-
lished data).
We next analyzed mitotic TC7 cells either treated or not
treated with LMB. TC7 cells were synchronized by a thymi-
dine block into S-phase, released and treated with LMB for
20 min, and infected with Ad2-TR for 1 h. The LMB-treated
cells enriched cytosolic adenovirus particles at both spindle
poles, unlike the control cells (Figure 5B). Importantly, the
LMB treated cells showed no obvious cytotoxicity or mitotic
defects and had normal spindle poles as judged by light
microscopy. In the untreated mitotic cells, the viruses were
dispersed throughout the cytoplasm not colocalizing with
MTs or the spindle poles (Figure 5B and unpublished data).
This stands in contrast to interphase TC7 cells where more
than 95% of Ad2-TR colocalized with MTs 40 min postinfec-
tion (Stidwill and Greber, 2000). The reason for the defect of
MT colocalization of adenovirus in mitotic cells is not due to
an irreversible impairment of the viruses by mitotic factors,
because Ad2-TR readily engaged with MTs after the cells
had completed mitosis (unpublished data). The data show
that MTs of normal mitotic cells fail to transport adenovi-
ruses to the spindle poles, consistent with the notion that
CRM1 or a CRM1-associated factor blocks viral attachment
to MTs in the mitotic cytoplasm, including the spindle MTs
and the poles. Interestingly, CRM1 immunoreactivity was
found throughout the cytosol and on the spindle of mitotic
TC7 cells in both control and LMB-treated cells (unpub-
lished data), suggesting that the mitotic localization of
CRM1 is independent of its NES-binding function. Nonethe-
less, the inhibition of mitotic CRM1 by LMB blocked viral
transport at the spindle poles.
CRM1 Is Required for Ad2 Disassembly at the NPC and
Nuclear Import
Infection requires capsid disassembly and disassembly in
turn depends on the association of capsids with the NPC
(Trotman et al., 2001). We therefore characterized the sub-
cellular localizations of Ad2 in interphase cells lacking func-
tional CRM1 in three different cell lines, TC7, A549, and
HeLa cells, 60 min postinfection. Quantitative EM analyses
indicated that LMB strongly reduced the number of virus
particles at the nuclear membrane of all cell types, but did
not significantly affect the number of cytosolic-, endosomal-,
and plasma membrane–associated particles, indicating that
LMB did not affect virus entry into the cytosol (Figure 6). To
assess the status of the cytosolic capsids that failed to asso-
ciate with the NPC, we analyzed capsid disassembly in both
TC7 and HeLa cells using the disassembly-specific anti-
hexon antibody R70 (Baum et al., 1972; Trotman et al., 2001).
The results show that the MTOC-arrested Ad2-TR capsids
were largely devoid of R70 epitopes in the LMB-treated TC7
cells but were strongly R70-positive in the control cells (Fig-
ure 7A). Likewise, LMB strongly inhibited the R70 staining
of the randomly dispersed cytosolic Ad2 in HeLa cells (Fig-
ure 7B). These results were confirmed by immunostainings
of the viral DNA-associated protein VII, which is protected
in the intact capsid and not accessible to antibodies by
immunofluorescence analyses, unless detached from the
capsid (Greber et al., 1997). LMB strongly blocked the ap-
pearance of protein VII in the nucleus of infected TC7 and
HeLa cells (Figure 7). This result was further confirmed by
fluorescence in situ hybridizations monitoring the incoming
viral genome. In LMB-treated TC7 cells the viral DNA was
absent from the nucleoplasm but enriched in a perinuclear
punctum and smaller cytoplasmic dots reinforcing the no-
tion that CRM1 is necessary for targeting functional adeno-
viruses from the MTs to the NPC and presenting them to the
disassembly machinery.
DISCUSSION
Viral invasion of the nucleus depends on the coordination of
many host functions. This facilitates the propagation of, for
example, adenoviruses in almost all vertebrates (Davison et
al., 2003). Of the more than 50 human adenovirus serotypes,
the respiratory viruses Ad2 and Ad5 cause severe infections
in immunocompromised patients (Horwitz, 2001). In modi-
fied forms these vectors are widely used for gene transfer
(Russell, 2000). They enter epithelial cells by clathrin-mediated
endocytosis, activate macropinocytosis, escape to the cytosol in
an integrin-dependent manner, and efficiently deliver their
DNA genome into the nucleus (Meier et al., 2002; Imelli et al.,
2004). Cytosolic particles are transported on preferentially sta-
ble MTs by the dynein/dynactin motor complex toward the
MTOC, often located near the nucleus (Suomalainen et al., 1999;
Leopold et al., 2000; Giannakakou et al., 2002). The first viruses
reaching the nucleus are those trafficking near the MTOC,
suggesting that this region is critical to hand over the viruses
from the MTs to the nuclear membrane. It is unknown how
viruses are detached from MTs.
Here we provide evidence linking two previously uncon-
nected pathways, nuclear export and cytoplasmic transport
on microtubules. Our in vivo results provide a molecular
explanation for the observation that enucleated human epi-
thelial cells arrested Ad5 particles at the MTOC (Bailey et al.,
2003). Using CRM1-specific drugs and siRNAs, we show
that the export factor CRM1 acts as a positional indicator of
the nucleus for the incoming adenovirus. If CRM1 function
Figure 6. Inhibition of nuclear envelope targeting of adenovirus in
TC7, A549, and HeLa cells. Quantitative subcellular analyses of Ad2
by thin-section EM in LMB-treated and control TC7, A549, and
HeLa cells. Viral particles (v.p.) were counted at the nuclear mem-
brane (A), in the cytosol (B), endosomes (C), and at the plasma
membrane (D). Results indicate the means and SE from the number
of analyzed cells and v.p.
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is blocked, the detachment of adenoviruses from the MTs
fails and viral binding to the nuclear membrane is pre-
vented. In normal cells, CRM1 predominantly localizes to
the nucleus and functions to export NES-containing proteins
from the nucleus to the cytoplasm (reviewed in Cullen, 2003;
Greber and Fornerod, 2005). It is potently inhibited by the
bacterial polyketides LMB and RJA. These inhibitors are
highly specific because 1) an Schizosaccharomyces pombe
strain expressing an LMB-resistant CRM1 was found to be
insensitive to LMB and 2) LMB bound specifically to CRM1
in the low nanomolar range (Neville et al., 1997; Kudo et al.,
1999; Koster et al., 2003), exactly matching our experimental
conditions for blocking CRM1. Both LMB and RJA blocked
the transport of incoming adenoviruses at the MTOC in
many different cell types or apparently randomly in the
HeLa cytoplasm. A similar nuclear transport block was es-
tablished in HeLa cells by siRNA-mediated knock down of
CRM1. In the absence of functional CRM1, the adenoviruses
failed to detach from the MTs and the MTOC, did not bind
to NPCs, and did not disassemble and import the DNA into
the nucleus, which is normally mediated by the NPC and
associated proteins (Saphire et al., 2000; Trotman et al., 2001).
Thus, LMB and RJA are novel viral entry inhibitors, estab-
lishing a previously unknown postentry block of infections.
They are among a small number of compounds restricting
viral entry (McKinlay et al., 1992; Greber et al., 1994).
Host restriction factors are part of innate immunity reac-
tions against incoming retroviruses and are responsible for
the narrow host range of these viruses (Goff, 2004). Restric-
tions are targeted against the capsid protein before reverse
transcription. HIV, for example, overcomes these restrictions
by incorporating cyclophilin A, a modulator of the viral
sensitivity to innate immunity factors (Towers et al., 2003). In
addition, viruses that are targeted to the MTOC by the
dynein/dynactin motor complex, such as the adenovirus
and HIV could be subject to another postentry host restric-
tion point, degradation by the aggresomal pathway that
collects misfolded or otherwise abnormal proteins (Kopito,
2000). By recruiting CRM1 adenovirus could escape from
this restriction and target to the NPC for uncoating. Whether
CRM1 acts as a gatekeeper or is mobilized to the virus is not
known. We can envision several modes how CRM1 over-
comes an entry block. Normally, CRM1 mediates nuclear
export of a large variety of leucine-rich export sequence
containing substrates by forming a complex with the GTP-
bound form of the small GTPase Ran in the nucleus (Petosa
Figure 7. LMB inhibits adenovirus cap-
sid disassembly and nuclear import of
protein VII and viral DNA. LMB-treated
and control TC7 (A) and HeLa (B) cells
were infected with Ad2 for 150 min,
fixed, and immunostained for the disas-
sembled capsid protein hexon and the
DNA-associated core protein VII. The
merged stacks of the entire set of CLSM
sections are shown. Bar, 10 m. (C) LMB
blocks Ad2 DNA import into the nu-
cleus. TC7 cells were infected with Ad2
in the presence or absence of LMB for
180 min, processed for in situ hybridiza-
tion, and immunostained for lamins
A/B/C. Single CLSM sections across a
central plane of the cells are shown in-
cluding DIC. Bar, 10 m.
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Molecular Biology of the Cell3006
et al., 2004). It is possible that either CRM1 alone, a short-
lived CRM1-NES-Ran:GTP complex or an unknown NES-
containing nuclear protein interact with adenovirus. If
CRM1 alone interacted with adenovirus this interaction
could be of supraphysiological affinity independent of Ran
(Engelsma et al., 2004). In this case, CRM1 would stay bound
to the capsid until disassembly at the NPC had occurred. A
cytosolic CRM1-NES-Ran:GTP complex on the other hand
would be a regulated MT dislodging trigger, because it has
a limited life time owing to the hydrolysis of GTP activated
by the cytoplasmic RanGAP protein (Bednenko et al., 2003;
Quimby and Dasso, 2003). The chromatin-bound GTP/GDP
exchange factor RCC1 in turn activates the complex by
loading Ran:GTP and establishes a gradient across the nu-
clear membrane in intact cells and also around mitotic chro-
mosomes in cell-free systems (Kalab et al., 2002; Macara,
2002; Weis, 2002). This regulated scenario is attractive be-
cause it would account for our observation that adenovi-
ruses were prevented from association with both spindle
and astral MTs of mitotic cells. This block was relieved by
LMB leading to virus accumulation at the spindle poles. In
fact, experiments with Xenopus egg extracts have suggested
that CRM1 is in a complex with Ran:GTP proximal to mitotic
chromatin (Kalab et al., 2002), although it is not known if a
Ran:GTP gradient exists around chromosomes of epithelial
cells (Gorlich et al., 2003). Regardless, even if Ran:GTP were
randomly distributed in mitotic TC7 cells, it could account
for dislodging adenovirus particles from MTs. On exit of the
cells from mitosis, CRM1 would be retrieved to the newly
formed nucleus together with Ran:GTP and the cytosolic
adenoviruses could be transported to the nucleus using
microtubules, as observed in our studies. The scenario that a
NES-containing cargo alone unloads the incoming adenovi-
rus from the MTs is perhaps less likely because in mitotic
cells with mixed nuclear and cytoplasmic contents, LMB
was very effective at clustering viruses at the spindle poles,
very similar to MTOC clustering in interphase cells. This
suggests that the export function of CRM1 is not needed for
dislodging adenovirus from MTs.
There is yet another possibility to carry CRM1 to perinu-
clear MTs of interphase cells, namely via the nucleoporins
RanBP2 or Nup214/CAN, as suggested by the observation
of RanBP2 antigens at the MTOC (Salina et al., 2003). Nucleo-
porin extensions might be possible via extended conforma-
tions of the FG domains, which could amount to some
hundred nanometers. Regardless, the requirement of CRM1
for nuclear targeting of adenovirus is strong, because adeno-
viruses are retained at the MTOC even if the MTOC is
positioned in immediate vicinity to the nuclear membrane.
Interestingly, CRM1 has been found at low concentrations at
the MTOC and it was postulated to be required to control
centriole synthesis (Forgues et al., 2003). It is thus feasible
that CRM1 is part of a centrosomal network, including ki-
nases, phosphatases, scaffolding proteins, and nuclear enve-
lope proteins. Indeed, a small fraction of Ran is tightly
associated with the centrosome throughout the cell cycle
(Zimmerman and Doxsey, 2000; Keryer et al., 2003). Other
centrosomal proteins such as centrin and pericentrin shuttle
between the nucleus and the centrosome in an LMB-depen-
dent manner. This suggests that centrosomal activities can
be regulated by CRM1-dependent nuclear export involving
specific cargo proteins and Ran. It is thus possible that viral
infectivity is both positively and negatively regulated by
centrosomal or cytosolic CRM1, because very low concen-
trations of LMB or RJA increased Ad5 gene expressions.
Future experiments will investigate how CRM1 interacts
with cytosolic adenovirus or affects an active transport sys-
tem carrying perinuclear viruses. This will be crucial to
address the issues of innate immunity and host restrictions
as well as turnover and immunogenicity of vectors.
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